Health & Personal Care
HIGH
FDA DRUG
Omnipaque Injection Recalled by GE Healthcare for Particulate Matter in 866,570 vials (2026)
GE Healthcare recalled Omnipaque iohexol injection, 300 mg/mL, distributed nationwide in the United States. The Class II recall covers 866,570 vials due to particulate matter. Healthcare providers should stop use and contact GE Healthcare Ireland Limited for guidance.
OMNIPAQUE
Presence of